Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3286 to 3300 of 7691 results

  1. Public board meetings

    Friday 22 July at 1:30pm via Zoom. Agenda Apologies for absence To receive any apologies for absence. Declarations of interest To declare

  2. Technology appraisal guidance

    Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS. Browse technology...

  3. Kidney conditions: CKD urine albumin:creatinine ratio (IND144)

    This indicator covers the percentage of patients on the CKD register whose notes have a record of a urine albumin:creatinine ratio (or protein:creatinine ratio) test in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM109

  4. Transport Layer Security (TLS) 1.2 upgrade

    Information about transport layer security (TLS) 1.2 upgrade

  5. Standards and Indicators

    NICE quality standards set out priority areas for quality improvement in health and social care.

  6. Terms and conditions

    Terms and conditions for the National Institute for Health and Care Excellence

  7. CKS end user licence agreement

    CKS end user licence agreement

  8. Public task

    The National Institute for Health and Care Excellence's public task consists of the mandatory functions which it is under a legal duty to perform as...

  9. RWE Navigator feedback

    Please complete all the required fields before submitting the form. RWE Navigator feedback form 1. Please tell us about yourself. Which

  10. Healthcare professionals - shaping our work

    Healthcare professionals - shaping our work A wide range of healthcare professionals, including primary care colleagues, work with NICE to develop our

  11. Indicator advisory committee (IAC)

    We work with an independent indicator advisory committee (IAC) to develop indicators suitable for inclusion in the Quality and Outcomes Framework...

  12. Managed access

    Managed access allows patients to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.

  13. Artificial intelligence (AI) and digital regulations service

    NICE's leading role in designing a new service to support the development and adoption of AI and data-driven technologies in health and care.

  14. Life sciences: how to get your product to market

    Support for industry to engage with NICE during all stages of health technology development

  15. Commercial Liaison Team

    The Commercial Liaison Team (CLT) works with companies who are considering a patient access scheme for their drug or treatment. Patient access schemes